Literature DB >> 21094679

The Wnt/beta-catenin pathway in adrenocortical development and cancer.

Abeer El Wakil1, Enzo Lalli.   

Abstract

Signaling by the Wnt family of secreted glycolipoproteins plays key roles in embryonic development of organisms ranging from nematodes to mammals and is also implicated in several types of human cancers. Canonical Wnt signaling functions by regulating the translocation of β-catenin to the nucleus, where it controls key gene expression programs through interaction with Tcf/Lef and other families of transcription factors. Wnts can also act through non-canonical pathways that do not involve β-catenin activation, but implicate small GTPases/JNK kinase and intracellular calcium. Here we review recent studies that have revealed the expression of several components of Wnt/β-catenin signaling in the adrenal cortex and discovered a key role for this pathway in the regulation of proliferation/differentiation of progenitor cells and in tumorigenesis of that endocrine organ.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094679     DOI: 10.1016/j.mce.2010.11.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  48 in total

Review 1.  Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.

Authors:  Derek P Simon; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2012-01-13       Impact factor: 4.102

2.  Genomic and immunohistochemical analysis in human adrenal cortical neoplasia reveal beta-catenin mutations as potential prognostic biomarker.

Authors:  Alexandra E Kovach; Carmelo Nucera; Quynh T Lam; Ahnthu Nguyen; Dora Dias-Santagata; Peter M Sadow
Journal:  Discoveries (Craiova)       Date:  2015 Apr-Jun

3.  Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Authors:  Francesco Fallo; Isabella Castellano; Celso E Gomez-Sanchez; Yara Rhayem; Catia Pilon; Valentina Vicennati; Donatella Santini; Valeria Maffeis; Ambrogio Fassina; Paolo Mulatero; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

4.  Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma.

Authors:  Derek P Simon; Thomas J Giordano; Gary D Hammer
Journal:  Clin Cancer Res       Date:  2012-03-16       Impact factor: 12.531

Review 5.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

6.  Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function.

Authors:  A Berthon; F R Faucz; S Espiard; L Drougat; J Bertherat; C A Stratakis
Journal:  Hum Mol Genet       Date:  2017-09-15       Impact factor: 6.150

7.  Methylation of SFRP5 is related to multidrug resistance in leukemia cells.

Authors:  H Wang; X Wang; R Hu; W Yang; A Liao; C Zhao; J Zhang; Z Liu
Journal:  Cancer Gene Ther       Date:  2014-01-17       Impact factor: 5.987

8.  Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.

Authors:  Yanyuan Wu; Charles Ginther; Juri Kim; Nicole Mosher; Seyung Chung; Dennis Slamon; Jaydutt V Vadgama
Journal:  Mol Cancer Res       Date:  2012-10-15       Impact factor: 5.852

9.  Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.

Authors:  Beatrice Rubin; Daniela Regazzo; Marco Redaelli; Carla Mucignat; Marilisa Citton; Maurizio Iacobone; Carla Scaroni; Corrado Betterle; Franco Mantero; Ambrogio Fassina; Raffaele Pezzani; Marco Boscaro
Journal:  Tumour Biol       Date:  2016-07-28

Review 10.  Lessons from the gene expression pattern of the rat zona glomerulosa.

Authors:  Koshiro Nishimoto; William E Rainey; Wendy B Bollag; Tsugio Seki
Journal:  Mol Cell Endocrinol       Date:  2012-12-31       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.